European Journal of Pharmacology 2000-03-31

Evidence for the involvement of ATP, but not of VIP/PACAP or nitric oxide, in the excitatory effect of capsaicin in the small intestine.

L Barthó, Z Lázár, L Lénárd, R Benkó, G Tóth, B Penke, J Szolcsányi, C A Maggi

Index: Eur. J. Pharmacol. 392(3) , 183-8, (2000)

Full Text: HTML

Abstract

The contractile effect of capsaicin in the guinea-pig small intestine involves an activation of enteric cholinergic neurons. Our present data show that the P(2) purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 30 microM) significantly reduces the contractile response to capsaicin (2 microM) in the presence, but not in the absence, of the tachykinin receptor antagonists [O-Pro(9), (Spiro-gamma-lactam)Leu(10), Trp(11)]physalaemin (1-11) (GR 82334; 3 microM) and (S)-(N)-(1-(3-(1-benzoyl-3-(3, 4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidine-4-yl)-N -methylacetamide (SR 142804: 100 nM) (for blocking tachykinin NK1 and NK3 receptors, respectively). PPADS (30 microM) fails to influence submaximal cholinergic contractions evoked by cholecystokinin octapeptide (CCK-8; 2-3 nM) or senktide (1 nM), or the direct smooth muscle-contracting effect of histamine (100-200 nM). A higher concentration (300 microM) of PPADS is also without effect against the stimulatory action of cholecystokinin octapeptide. This means that PPADS can probably be safely used as a purinoceptor antagonist in intestinal preparations. The putative pituitary adenylate cyclase activating peptide (PACAP) receptor antagonist PACAP-(6-38) (3 microM) significantly reduces the contractile effect of PACAP-(1-38) (10 nM) and abolishes that of vasoactive intestinal polypeptide (VIP; 10 nM). PACAP-(6-38) (3 microM) fails to influence the effect of capsaicin (2 microM) both in the absence and in the presence of tachykinin receptor antagonists. The nitric oxide (NO) synthase inhibitor N(G)-nitro-L-arginine (L-NOARG; 100 microM) also fails to inhibit the capsaicin-induced motor response. We conclude that an endogenous ligand of PPADS-sensitive P(2) purinoceptors (possibly ATP), but not a VIP/PACAP-like peptide or NO, is involved in the nontachykininergic activation of cholinergic neurons in the course of the capsaicin-induced contraction.


Related Compounds

  • GR 82334

Related Articles:

Effect of tachykinins on ascending and descending reflex pathway in rat small intestine.

2002-04-01

[Acta Pharmacol. Sin. 23(4) , 289-95, (2002)]

Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes.

2003-04-01

[Br. J. Pharmacol. 138(7) , 1233-43, (2003)]

Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.

2004-07-01

[Naunyn Schmiedebergs Arch. Pharmacol. 370(1) , 35-45, (2004)]

Substance P sensitizes P2X3 in nociceptive trigeminal neurons.

2010-10-01

[J. Dent. Res. 89(10) , 1154-9, (2010)]

Increased ganglionic responses to substance P in hypertensive rats due to upregulation of NK(1) receptors.

2000-11-01

[Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(5) , R1685-94, (2000)]

More Articles...